Delivery Order SPE2DB22D9311-SPE2DB25FP6XD

Award Date 1/29/25
Potential Completion Date 1/30/25
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $28,696.68 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the BOOSTRIX TDAP vaccine syringe, 0.5 mL, with a completion date of June 14, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $6,815.90 firm fixed-price contract is for the procurement of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a pharmaceutical product, with a period of performance ending on January 17, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA). The $33,760.80 firm fixed-price delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which provides a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. The...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,807.60 firm fixed-price contract is for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue...
This is a delivery order under a $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, and the U.S. Defense Logistics Agency (DLA). The order is for BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, with a ceiling value of $14,067.00 and a firm fixed price. The contract has no set-aside designation. DMS Pharmaceutical Group provides a wide range of pharmaceutical products and medical supplies to support the recurring...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the BOOSTRIX TDAP VACCINE VIAL 0.5ML. This order, valued at $2,790.70, is part of a larger indefinite delivery contract that DMS Pharmaceutical Group holds with the Defense Logistics Agency to supply a variety of pharmaceutical items and medical supplies, including medications, vaccines, and other products, to support military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,566,195,547 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML product, with a ceiling value of $4,782.78. The contract is a firm fixed-price delivery order with an ultimate completion date of October 23, 2024. DMS Pharmaceutical Group Inc. holds a significant...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of Boostrix Tdap vaccine vials with a completion date of January 11, 2024. The potential value of the contract is $1,395.35. This contract is not associated with a set-aside program. DMS Pharmaceutical Group Inc. is an experienced pharmaceutical wholesaler that holds multiple federal...
The federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,880.40 firm fixed-price delivery order is for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to fulfill the recurring medical supply needs of military health facilities. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under the SPE2DB program to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,219.04 delivery order is for the supply of ADACEL TDAP VIAL, with a completion date of June 20, 2024. The order is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the...
  • SPE2DB22D9311
    Indefinite Delivery Contract
  • SPE2DB22D9311-SPE2DB25FP6XD
    Delivery Order

This is a firm fixed-price delivery order for the procurement of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract has a ceiling value of $3,409.68 and a period of performance through January 30, 2025. DMS Pharmaceutical Group Inc. is an established federal contractor that has participated in multiple DLA contracts, including a $499,999,999 Indefinite Delivery Contract (IDC) to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities. This delivery order is not associated with a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure the award directly from the DLA.

Generated 4/30/25, 9:59 AM